Literature DB >> 31661015

Correction to: Does a Screening Trial for Spinal Cord Stimulation in Patients with Chronic Pain of Neuropathic Origin have Clinical Utility and Cost-Effectiveness? (TRIAL-STIM Study): study protocol for a randomised controlled trial.

Sam Eldabe1, Ashish Gulve1, Simon Thomson2, Ganesan Baranidharan3, Rui Duarte4, Susan Jowett5, Harbinder Sandhu6, Raymond Chadwick7, Morag Brookes1, Anisah Tariq1, Jenny Earle8, Jill Bell8, Anu Kansal1, Shelley Rhodes9, Rod S Taylor9.   

Abstract

Following publication of the original article [1], we have been notified that the final specification of randomisation implemented in the study is slightly different to that stated in the protocol and needs to be corrected as follows.

Entities:  

Year:  2019        PMID： 31661015      PMCID： PMC6816184          DOI： 10.1186/s13063-019-3804-7

Source DB:  PubMed          Journal:  Trials        ISSN： 1745-6215            Impact factor:   2.279


Correction to: Trials (2018) 19: 633 https://doi.org/10.1186/s13063-018-2993-9 Following publication of the original article [1], we have been notified that the final specification of randomisation implemented in the study is slightly different to that stated in the protocol and needs to be corrected as follows: Allocation will be stratified by centre and minimised on patient age (≥ 65 or < 65 years), gender, and presence of FBSS or not
  1 in total

1.  Does a Screening Trial for Spinal Cord Stimulation in Patients with Chronic Pain of Neuropathic Origin have Clinical Utility and Cost-Effectiveness? (TRIAL-STIM Study): study protocol for a randomised controlled trial.

Authors:  Sam Eldabe; Ashish Gulve; Simon Thomson; Ganesan Baranidharan; Rui Duarte; Susan Jowett; Harbinder Sandhu; Raymond Chadwick; Morag Brookes; Anisah Tariq; Jenny Earle; Jill Bell; Anu Kansal; Shelley Rhodes; Rod S Taylor
Journal:  Trials       Date:  2018-11-16       Impact factor: 2.279
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.